Concepedia
Statistics
Publications
24
Citations
972
H-Index
19
Active since
2004
Affiliations
Medical University of Białystok(Current)
Jagiellonian University
University of Hyogo
Lodz University of Technology
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy
Andrzej Mogielnicki is an author at Medical University of Białystok specializing in medicine, pharmacology, and pharmacotherapy.
Top concepts
MedicinePharmacologyThrombosisPharmacotherapyVascular BiologyMolecular PharmacologyPhysiologyHypertensionCardiovascular DiseaseAtherosclerosis
Publications per year
2004–2020
1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway
J Świȩs, Andrzej Mogielnicki, W Buczko et al. · British Journal of Pharmacology · 2007 · 198 citations · Full text
The physiological significance of the alternative pathways of angiotensin II production.
Karol Kramkowski, Andrzej Mogielnicki, W Buczko · PubMed · 2006 · 96 citations
Hypertension, Cardiovascular Pharmacology, Ang Ii +20
Antithrombotic Properties of Water-Soluble Carbon Monoxide-Releasing Molecules
Karol Kramkowski, Agnieszka Leszczyńska, Andrzej Mogielnicki et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 58 citations · Full text
Angiotensin II enhances thrombosis development in renovascular hypertensive rats
Andrzej Mogielnicki, Ewa Chabielska, Robert Pawlak et al. · Thrombosis and Haemostasis · 2005 · 56 citations
Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats.
M. Kamińska, Andrzej Mogielnicki, Adrian Stankiewicz et al. · PubMed · 2005 · 54 citations
Hypertension, Vascular Disease, Ang Ii Effect +21
1–5 of 24